Introduction
At delivery children with congenital hypothyroidism have a length similar to that of healthy children, but without re placement therapy with L-thyroxine (L-T4) their growth rate diminishes shortly afterwards [2, 4, 7] . A continuing decrease or even complete arrest of statural growth is ob served if congenital or acquired juvenile hypothyroidism remains untreated. It has been suggested that adequate treatment of hypothyroidism leads to complete catch-up growth and a normal adult stature [4, 12, 16] . It is now clear that short stature can indeed be prevented if L-T4 substitution is started at an early age [1, 3] , but if hy pothyroidism remains untreated for a longer period a per manent height loss cannot always be avoided [2, 11, 13] . However, the number of reported clinical observations on long-term growth after prolonged untreated hypothy roidism is still relatively small [2, 4, 11, 13] and most of these studies did not involve the parental heights and the pre-illness growth curve in the estimation of the loss in adult height.
We present a description of four patients in whom hy pothyroidism was left untreated for long period and dis cuss its consequences for catch-up growth.
Patients
Patient 1 A girl of Indonesian origin developed feeding difficulties shortly after birth requiring hospitalisation. Congenital hypothyroidism was diagnosed and L-T4 replacement therapy was started. Therapy was dis continued after 4 months as a result of parental ignorance and the patient was lost to follow up. Finally, at the age of 13.9 years, she visited our clinic because she had become extremely slow. Physical examination showed a prepubertal, clearly apa thetic, mentally retarded girl unable to speak and walk, with a height of 81 cm (3rd percentile = 151.2 cm) and a weight of 13.4 kg (3rd percentile = 37.3 kg). Her face showed coarse, puffy fea tures with la T g e lips and a big tongue, a flat nose and myxoedema 363 F ig .l a Patient 1 before the start of therapy at the age of 13.9 years, b Patient after 6 months of therapy Fig. la) . She had brittle hair and a pale skin. The abdomen was distended and an umbilical hernia was present, while her arms showed slight contractures and her legs were strongly bowed. Her psychomotor development was equal to that of a child at the age of 13 months. Additional investigations showed a serum total T4 < 13 nmol/1, free thyroxine index (FTI) < 13, TSH > 60 mU/1 and cholesterol 11.0 mmol/1. X-ray investigations revealed stippled epiphyses of the femoral heads, immature vertebrae and bowed tibiae, L-T4 substitution therapy was resumed and followed by a remarkable improvement of clinical symptoms (Fig. lb) . The first manifestations of pubertal development were noted within 8 months.
slightly obese girl with a pale coloured skin and a heart rate of 44 beats/min. She had hypertrichosis on the back, arms and legs, but no further signs of virilisation could be detected. Her* psychologi cal development was norma]. Tanner stages were B3P3 and menarche had not occurred. Additional investigations showed a to tal T4 of 5 nmol/1, FTI < 2 and TSH 580 mU/l and cholesterol 13,7 mmol/I. The presence of anticolloidal antibodies was dubious and antinuclear antibodies were weakly positive. The levels of circu lating androgens were normal, Primary hypothyroidism was diag nosed, probably due to Hashimoto thyroiditis, and L-T4 substitu tion therapy was started. The hypertrichosis was of familiar origin. Pubertal development progressed and menarche occurred at the age of 14.5 years.
Patient 2
A 14-year-old boy was referred because of growth failure. At the age of 13 years he had undergone a surgical correction for epiphysiolysis of both femoral heads. Physical examination showed a boy with a pale, puffy face and skin depigmentation. Tanner stages were A1P1G1 but the testicular volume was 12 ml. H is IQ was normal. Additional investigations showed a total T4 o f 10 nmol/1, free T4 0.8 pinol/1 and TSH 367 mU/1. Microsomal antibodies were positive and thyroglobulin antibodies negative. Plasma testosterone was 1.3 nmol/1. Cortisol secretion was nor mal. He was diagnosed as having primary hypothyroidism, prob ably due to Hashimoto thyroiditis and L-T4 substitution therapy was started. Shortly thereafter a progression of genital devel opment was noted and within 10 months he had reached genital stage 4.
Patient 3
Patient 4 A nearly 6-year-old girl was referred because of abdominal pain, anorexia and fatigue. Physical examination showed a short, prepu bertal girl with a puffy, broad and round face, macroglossia and a pale skin. Her psychological development was normal. Additional investigations: total T4 22 nmol/1, FTI 19, TSH 60 mU/1, thy roglobulin antibodies and microsomal antibodies were absent. Xray investigations revealed stippled epiphyses of the femoral heads. On scintigraphy no thyroid gland could be visualised, but ectopic thyroid tissue was detected at the base of the tongue, which was consistent with the findings of indirect laryngoscopy. There fore she was diagnosed as having primary hypothyroidism proba bly resulting from decompensation of an ectopic dysgenetic thy roid gland and L-T4 substitution therapy was started. Pubertal de velopment started at the age of 10,7 years and menarche occurred at the age of 13.6 years.
A 13-year-old girl was referred because of growth failure and in creased body weight. She also reported increased hair growth and a lowered voice. Physical examination showed an apathetic and until the age of 22 years but still ended up 15.5 cm below the initial height deficit in all patients, three of them did s. in patients 1 and 4 and by the history of epiphysiolysis in patient 2. However, although it has been reported that hy pothyroidism indeed causes damage to the epiphyseal growth plate cartilage, this proved to be fully reversible during L-T4 treatment [8] . Therefore it is questionable whether this explains incomplete catch-up growth in our patients.
Although thyroid hormones are indeed important stim ulators of skeletal maturation, it is also unlikely that overtreatment with L-T4 has caused incomplete catch-up growth in these patients. They all received the recom mended daily dosage of 100 jug/m2 L~T4 and none of them showed clinical or biochemical evidence of excess of thyroid hormones.
The third explanation seems to correspond best with the observations in our patients. Patient 1 entered puberty shortly after the start of treatment and failed to reach her target height. Patients 2 and 3 already showed signs of pu bertal development at the start of treatment and failed to return to the pre-illness percentile position or to reach tar get height. Patient 4 entered into puberty more than 4 years after the start of treatment and she was the only pa tient who reached nearly complete catch-up growth. These observations seem to confirm that if l-T4 substitu tion is initiated at the moment that the patient has already entered puberty or if pubertal onset occurs shortly thereafter, catch-up growth is incomplete. Sex steroids proba bly induce a disproportional acceleration of bone matura tion in relation to linear growth, which finally results in epiphyseal fusion before complete catch-up growth has been reached.
A recent case report showed that suppression of pu bertal development by administration of synthetic go nadotropin releasing hormone plus growth hormone im proved height gain in a patient with juvenile hypo thyroidism [9] . This approach of gonadal suppression in combination with growth hormone therapy in order to improve final height is sometimes also applied in conditions such as idiopathic short stature [6, 14] , idio pathic growth hormone deficiency [5, 17] and precocious puberty [10, 15] . It is tempting to speculate that the out come of catch-up growth in the first three of the herein described patients might have been better if they had been treated according to this new therapeutic strategy.
In summary, hypothyroidism exerts profound effects on human growth. Nevertheless, even after an extremely long period of thyroid dysfunction the capacity to estab lish a striking catch-up growth spurt remains intact. How ever, catch-up may be incomplete in patients in whom therapy is started shortly before or during puberty.
